Cornerstone Pharmaceuticals Appoints Dr. Dorit Arad Director of Research and Development for its Israeli Operations

CRANBURY, New Jersey, August 17, 2010 – Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today
announced that Dorit Arad, Ph.D., has been appointed director of research and
development for the company's operations in Israel. Cornerstone
Pharmaceuticals is establishing development and clinical research and trial
collaborations with leading scientists and physician investigators.
Cornerstone is the leader in the discovery and [...]

Automated Cell Biology Workflows with Tecan and Miltenyi Biotec

BERGISCH GLADBACH, Germany, and MANNEDORF, Switzerland, August 17, 2010 – Tecan is working with Miltenyi Biotec, a leading provider of cell biology
solutions, to develop a range of automated solutions for cell biology, based
on the powerful MACS(R) Magnetic bead technology. This new agreement will
allow customers to benefit from the advanced capabilities of Tecan's Freedom
EVO(R) liquid [...]

Lilly Halts Development of Semagacestat for Alzheimer’s Disease Based on Preliminary Results of Phase III Clinical Trials

Decision does not affect other Lilly Alzheimer's compounds in development

INDIANAPOLIS, August 17, 2010 – Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat,
a gamma secretase inhibitor being studied as a potential treatment for
Alzheimer's disease, because preliminary results from two ongoing long-term
Phase III studies showed it did not slow disease progression and was
associated [...]

U.S. Market for Video, High-Tech and Integrated OR Equipment 2010 Now Available at ReportsandReports

DALLAS, August 17, 2010 – ReportsandReports announces it will carry the U.S. Market for Video,
High-Tech and Integrated OR Equipment 2010 Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/us-market-for-video-high-tech
-and-integrated-or-equipment-2010/
Report Summary
In 2009, the U.S. market for video and high-tech equipment was valued at
nearly [...]

Kowa Announces First EU Marketing Authorisation for Pitavastatin Granted in the UK

Statin Licenced to Treat Patients With Primary Hypercholesterolaemia or Combined Dyslipidemia

WOKINGHAM, England, August 17, 2010 – Kowa are delighted to announce that the Medicines and Healthcare products
Regulatory Agency (MHRA) has granted a UK licence for their statin, Livazo(R)
(pitavastatin). This follows the completion of the decentralized regulatory
procedure, in which the MHRA delivered a positive outcome [...]

International Society for Cellular Therapy (ISCT) Joins Forces With Roche and Genzyme to Launch Cell Therapy Industry Partnership

VANCOUVER, August 16, 2010 – Many companies in the cell therapy regenerative medicine market including
Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life
Technologies will join ISCT to launch a series of new initiatives that will
create greater strategic alignment within the industry and drive late stage
clinical development.

The ISCT Industry Task Force [...]

Interventional Spine(R), Inc. Announces Continued Success With Its Unique PERPOS(R) Percutaneous Cervical System

IRVINE, California, August 16, 2010 – Interventional Spine, Inc. today announced the completion of another
successful surgery with the unique PERPOS Percutaneous Cervical System for
the treatment of neck pain.

(Logo: photos.prnewswire.com/prnh/20100419/LA88318LOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20100419/LA88318LOGO)

To the Company's knowledge, the PERPOS Percutaneous Cervical System is
the only product that [...]

New Intra-Nasal Cooling System May Improve Survival When Initiated Soon After Cardiac Arrest

SAN DIEGO, California, August 16, 2010 – A new portable system which cools the brain via the nasal cavity may
improve survival following cardiac arrest compared with standard care
procedures, particularly when CPR and cooling are initiated early.
Results from a recent study showed that the RhinoChill(TM) Intra-Nasal
Cooling System enabled brain temperature to reach target several hours
earlier [...]

Human See, Human Do; Mirror Neurons in The Buying Brain Mimic Behavior

BERKELEY, California, August 16, 2010 – The breakthrough discovery started with an ice cream cone on a hot summer
day.

As Dr. A. K. Pradeep recounts in his new book, The Buying Brain: Secrets
for Selling to the Subconscious (buyingbrain.com/), a researcher in
Professor Giancomo Rizzolati's neuroscience laboratory at the University of
Parma in Italy [...]

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio

CLEVELAND, Ohio, August 16, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, will consolidate its eTrinsic custom courseware business
currently located in Denver, Colorado and relocate those operations to its
Corporate Headquarters in Cleveland, Ohio under its expanding Medical
Education Division (MED).

[...]

New Hope for Joint Pain Sufferers

BIRMINGHAM, England, August 16, 2010 – Osteoarthritis (flexeze.co.uk/) is a crippling disease worldwide,
with an estimated eight million sufferers in the UK alone. It has been
described as like "wearing a suit of rusty armour," with unrelenting,
razor-like pain.

So far medical science has not been able to reverse the degenerative
condition.
[...]

Cardio3 BioSciences Publishes the Science Basis for C-Cure(R) in JACC

Article Described a Landmark Process Generating Cardiac Precursor Cells to Rebuild Heart Tissue

MONT-SAINT-GUIBERT, Belgium, August 16, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular disease, today
announces that the key scientific work underlying its lead pharmaceutical
product C-Cure(R), a revolutionary stem cell treatment for heart failure, has
been [...]